938 related articles for article (PubMed ID: 29984648)
1. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of gallium-based drugs for antibacterial therapy.
Bonchi C; Imperi F; Minandri F; Visca P; Frangipani E
Biofactors; 2014; 40(3):303-12. PubMed ID: 24532037
[TBL] [Abstract][Full Text] [Related]
4. Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.
Boyd NK; Teng C; Frei CR
Front Cell Infect Microbiol; 2021; 11():684515. PubMed ID: 34079770
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy: the propitious rationale for drug development.
Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK
Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510
[TBL] [Abstract][Full Text] [Related]
6. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.
Wang CH; Hsieh YH; Powers ZM; Kao CY
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477
[TBL] [Abstract][Full Text] [Related]
7. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
Peyclit L; Baron SA; Rolain JM
Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
[TBL] [Abstract][Full Text] [Related]
8. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
[TBL] [Abstract][Full Text] [Related]
9. Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms.
Chromy BA; Elsheikh M; Christensen TL; Livingston D; Petersen K; Bearinger JP; Hoeprich PD
Future Microbiol; 2012 Aug; 7(8):1011-20. PubMed ID: 22913359
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of antibiotics to combat antimicrobial resistance.
Dubey KK; Indu ; Sharma M
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
[TBL] [Abstract][Full Text] [Related]
11. Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii.
Chopra S; Torres-Ortiz M; Hokama L; Madrid P; Tanga M; Mortelmans K; Kodukula K; Galande AK
J Antimicrob Chemother; 2010 Dec; 65(12):2598-601. PubMed ID: 20861141
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors.
Yssel AEJ; Vanderleyden J; Steenackers HP
J Antimicrob Chemother; 2017 Aug; 72(8):2156-2170. PubMed ID: 28575223
[TBL] [Abstract][Full Text] [Related]
13. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
[TBL] [Abstract][Full Text] [Related]
14. Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections.
Canturri AM; Smani Y
Curr Med Chem; 2022; 30(1):59-71. PubMed ID: 35838224
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing to overcome microbial resistance.
Jampilek J
Drug Discov Today; 2022 Jul; 27(7):2028-2041. PubMed ID: 35561965
[TBL] [Abstract][Full Text] [Related]
16. Repurposing bioactive compounds for treating multidrug-resistant pathogens.
Hummell NA; Kirienko NV
J Med Microbiol; 2020 Jun; 69(6):881-894. PubMed ID: 32163353
[No Abstract] [Full Text] [Related]
17. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
Viganor L; Howe O; McCarron P; McCann M; Devereux M
Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
[TBL] [Abstract][Full Text] [Related]
18. Overcoming Multidrug-Resistance in Bacteria with a Two-Step Process to Repurpose and Recombine Established Drugs.
Sun J; Wang B; Warden AR; Cui D; Ding X
Anal Chem; 2019 Nov; 91(21):13562-13569. PubMed ID: 31565925
[TBL] [Abstract][Full Text] [Related]
19. Antibiotics for emerging pathogens.
Fischbach MA; Walsh CT
Science; 2009 Aug; 325(5944):1089-93. PubMed ID: 19713519
[TBL] [Abstract][Full Text] [Related]
20. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
